GlycA Levels during the Earliest Stages of Rheumatoid Arthritis: Potential Use as a Biomarker of Subclinical Cardiovascular Disease

GlycA Levels during the Earliest Stages of Rheumatoid Arthritis: Potential Use as a Biomarker of Subclinical Cardiovascular Disease

This study aimed at evaluating the clinical relevance of glycoprotein profiles during the earliest phases of rheumatoid arthritis (RA) as biomarkers of cardiovascular (CV) risk and treatment response. Then, GlycA and GlycB serum levels were measured using 1H-nuclear magnetic resonance in 82 early RA...

Full description

Bibliographic Details
Main Authors: Javier Rodríguez-Carrio, Mercedes Alperi-López, Patricia López, Ángel I. Pérez-Álvarez, Miriam Gil-Serret, Núria Amigó, Catalina Ulloa, Lorena Benavente, Francisco J. Ballina-García, Ana Suárez
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Journal of Clinical Medicine
Subjects:
glycoproteins
early rheumatoid arthritis
cardiovascular risk
atherosclerosis
inflammation
H-NMR
Online Access:https://www.mdpi.com/2077-0383/9/8/2472

Internet

https://www.mdpi.com/2077-0383/9/8/2472

Similar Items